MTOR and Parkinson disease: We found a similar alteration in the PI3K-Akt-mTOR pathway in condition of GCase dysfunction in our PD models, both in primary macrophages from patients with GBA-PD and in the double toxic model MPTP+CBE-treated mice (Figure 6B).